drugset / Trial / NCT05663879
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of ID120040002 in Healthy Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
A Randomized, Double-blinded, Partial-open, Placebo and Active-controlled, Single and Multiple Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ID120040002 in Healthy Volunteers
Timeline
- Start
- 2022-12-07
- Primary completion
- 2023-07-31
- Completion
- 2023-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Compound-X | Unknown | — | — |
| Subject | ID120040002 | Unknown | — | — |
Indications
No indication recorded.